Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 1 Experimental design

Published byHope Logan Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig. 1 Experimental design"— Presentation transcript:

1 Fig. 1 Experimental design
Fig. 1 Experimental design. Dark arrows indicate time of injections of IGF-I into the amniotic fluid in the amniotic treatment groups. PM, Postmortem. From: Fetal and Amniotic Insulin-Like Growth Factor-I Supplements Improve Growth Rate in Intrauterine Growth Restriction Fetal Sheep Endocrinology. 2007;148(6): doi: /en Endocrinology | Copyright © 2007 by the Endocrine Society

2 Fig. 3 Fetal and maternal blood gases and hemoglobin concentrations
Fig. 3 Fetal and maternal blood gases and hemoglobin concentrations. A, Fetal PaO<sub>2</sub>. B, Fetal PaCO<sub>2</sub>. C, Fetal hemoglobin. D, Maternal PaO<sub>2</sub>. E, Maternal PaCO<sub>2</sub>. F, Maternal hemoglobin. Data are analyzed by repeated measures ANOVA with Tukey post hoc test and values are mean ± se. •, Control (n = 10–5); ○, SAL (n = 13–6); ▪, IGF-AF (n = 11–5); □, IGF-NUT (n = 13–6), ▴, IGF-IV (n = 11–5). Animal numbers decreased over the study period due to attrition (see Table 1). *, P ≤ 0.05, **, P ≤ 0.01, ****, P ≤ for time effects; upper-case letters represent group effects, and lower-case letters represent post hoc significance of the group × time interaction. <sup>C/c</sup>P ≤ 0.05 vs. control; <sup>S/s</sup>P ≤0.05 vs. SAL; <sup>A/a</sup>P ≤ 0.05 vs. IGF-AF; <sup>N/n</sup>P ≤ 0.05 vs. IGF-NUT; <sup>I/i</sup>P ≤ 0.05 vs. IGF-IV; <sup>ALL/all</sup>P ≤ 0.05 vs. all other groups. From: Fetal and Amniotic Insulin-Like Growth Factor-I Supplements Improve Growth Rate in Intrauterine Growth Restriction Fetal Sheep Endocrinology. 2007;148(6): doi: /en Endocrinology | Copyright © 2007 by the Endocrine Society

3 Fig. 2 Fetal chest girth increments
Fig. 2 Fetal chest girth increments. Values are normalized for 93 dGA and expressed as mean ± se. •, Control (n = 6); ○, SAL (n = 10); ▪, IGF-AF (n = 5); □, IGF-NUT (n = 6); ▴, IGF-IV (n = 5). The gray horizontal bar indicates period of embolization. Mean daily girth increments are reduced in embolized groups during the embolization period (Table 2, not indicated in figure). Upper-case letters indicate group effects during the treatment period (<sup>S</sup>P ≤ 0.05 vs. SAL; <sup>N</sup>P ≤ 0.05 vs. IGF-NUT). From: Fetal and Amniotic Insulin-Like Growth Factor-I Supplements Improve Growth Rate in Intrauterine Growth Restriction Fetal Sheep Endocrinology. 2007;148(6): doi: /en Endocrinology | Copyright © 2007 by the Endocrine Society

4 Fig. 4 Fetal and maternal arterial and amniotic fluid metabolite concentrations. A, Fetal glucose. B, Fetal lactate. C, Fetal urea. D, Maternal glucose. E, Maternal lactate. F, Maternal urea. G, Amniotic fluid glucose. H, Amniotic fluid lactate. I, Amniotic fluid urea. Data are analyzed by repeated-measures ANOVA with Tukey post hoc test and values are mean ± se. •, Control (n = 10–6); ○, SAL (n = 12–7); ▪, IGF-AF (n = 12–6); □, IGF-NUT (n = 11–7); ▴, IGF-IV (n = 11–5). Animal numbers decreased throughout the study period due to attrition (see Table 1). *, P ≤ 0.05, **, P ≤ 0.01, ***, P ≤ 0.001, ****, P ≤ for time effects; upper-case letters represent group effects, and lower-case letters represent post hoc significance of the group × time interaction. <sup>C/c</sup>P ≤ 0.05 vs. control; <sup>S/s</sup>P ≤ 0.05 vs. SAL; <sup>A/a</sup>P ≤ 0.05 vs. IGF-AF; <sup>N/n</sup>P ≤ 0.05 vs. IGF-NUT; <sup>I/i</sup>P ≤ 0.05 vs. IGF-IV; <sup>ALL/all</sup>P ≤ 0.05 vs. all other groups. From: Fetal and Amniotic Insulin-Like Growth Factor-I Supplements Improve Growth Rate in Intrauterine Growth Restriction Fetal Sheep Endocrinology. 2007;148(6): doi: /en Endocrinology | Copyright © 2007 by the Endocrine Society

5 Fig. 5 Fetal and maternal arterial and amniotic fluid IGF-I and insulin concentrations. A, Fetal IGF-I. B, Fetal insulin. C, Maternal IGF-I. D, Maternal insulin. E, Amniotic fluid IGF-I. Data are analyzed by repeated-measures ANOVA with Tukey post hoc test and values are mean ± se. •, Control (n = 9–4); ○, SAL (n = 13–7); ▪, IGF-AF (n = 12–6); □, IGF-NUT (n = 11–6); ▴, IGF-IV (n = 10–5). Animal numbers decreased over the study period due to attrition (see Table 1). *, P ≤ 0.05, **, P ≤ 0.01, ****, P ≤ for time effects; upper-case letters represent group effects, and lower-case letters represent post hoc significance of the group × time interaction. <sup>C/c</sup>P ≤ 0.05 vs. control; <sup>S/s</sup>P ≤ 0.05 vs. SAL; <sup>A/a</sup>P ≤ 0.05 vs. IGF-AF; <sup>N/n</sup>P ≤ 0.05 vs. IGF-NUT; <sup>I/i</sup>P ≤ 0.05 vs. IGF-IV; <sup>ALL/all</sup>P ≤ 0.05 vs. all other groups. From: Fetal and Amniotic Insulin-Like Growth Factor-I Supplements Improve Growth Rate in Intrauterine Growth Restriction Fetal Sheep Endocrinology. 2007;148(6): doi: /en Endocrinology | Copyright © 2007 by the Endocrine Society

Download ppt "Fig. 1 Experimental design"

Similar presentations

Figure 1. Lateral radioventriculograph showing the location of the fourth ventricle in a sheep and determination of the target for fourth ventricular cannulation.

Figure 1. Lateral radioventriculograph showing the location of the fourth ventricle in a sheep and determination of the target for fourth ventricular cannulation.
Maternal protein restriction during pregnancy and lactation in rats imprints long-term reduction in hepatic lipid content selectively in the male offspring 

Maternal protein restriction during pregnancy and lactation in rats imprints long-term reduction in hepatic lipid content selectively in the male offspring 
Figure 1 Developmental and T3-induced changes in trb, klf9, and thbzip mRNAs in X laevis tadpole brain. The middle region of the brain (preoptic.

Figure 1 Developmental and T3-induced changes in trb, klf9, and thbzip mRNAs in X laevis tadpole brain. The middle region of the brain (preoptic.
Maternal taurine supplementation attenuates maternal fructose-induced metabolic and inflammatory dysregulation and partially reverses adverse metabolic.

Maternal taurine supplementation attenuates maternal fructose-induced metabolic and inflammatory dysregulation and partially reverses adverse metabolic.
Fig. 1. Baseline and 3-month infusion protocol

Fig. 1. Baseline and 3-month infusion protocol
Figure 6. Clock time changes (means ± standard error of the mean) of gene expression of natriuretic peptides in the atrium of control (open bars) and melatonin-treated.

Figure 6. Clock time changes (means ± standard error of the mean) of gene expression of natriuretic peptides in the atrium of control (open bars) and melatonin-treated.
Fig. 1. Body growth and leptin responsivity in young CPO and CTR mice

Fig. 1. Body growth and leptin responsivity in young CPO and CTR mice
Figure 1 Plasma LH concentration (mean ± SEM) in llamas after IUI of PBS (n = 6) or seminal plasma (n = 6) or after mating with an urethrostomized (n =

Figure 1 Plasma LH concentration (mean ± SEM) in llamas after IUI of PBS (n = 6) or seminal plasma (n = 6) or after mating with an urethrostomized (n =
Fig. 1 Upper panel, Autoradiographs of LD or SD female Siberian hamster brain sections (20-μm coronal sections; 8 wk postweaning) after in situ hybridization.

Fig. 1 Upper panel, Autoradiographs of LD or SD female Siberian hamster brain sections (20-μm coronal sections; 8 wk postweaning) after in situ hybridization.
Romiplostim promotes platelet recovery in a mouse model of multicycle chemotherapy- induced thrombocytopenia  Patricia L. McElroy, Ping Wei, Keri Buck,

Romiplostim promotes platelet recovery in a mouse model of multicycle chemotherapy- induced thrombocytopenia  Patricia L. McElroy, Ping Wei, Keri Buck,
Fig. 2 Patterns of twice-weekly plasma P in C, T60, CP, and TP sheep (n = 6/group) during the first breeding season (P1), anestrous season (P2; shaded.

Fig. 2 Patterns of twice-weekly plasma P in C, T60, CP, and TP sheep (n = 6/group) during the first breeding season (P1), anestrous season (P2; shaded.
Figure 1. Circadian pattern of gastric pH in healthy control subjects documented before (P1) Ramadan, on the 10th day (P2) and on the 24th day (P3) of.

Figure 1. Circadian pattern of gastric pH in healthy control subjects documented before (P1) Ramadan, on the 10th day (P2) and on the 24th day (P3) of.
Figure 3. Effect of LHRH-A (10−6m) on the IGF-I-induced tyrosine phosphorylation of the IGF-IR in DU 145 cells. LHRH-A was added to the experimental.

Figure 3. Effect of LHRH-A (10−6m) on the IGF-I-induced tyrosine phosphorylation of the IGF-IR in DU 145 cells. LHRH-A was added to the experimental.
Fig. 1. Fetal GSIS. Fetal plasma glucose (A) and insulin (B) concentrations determined for the in vivo GSIS study are presented as the mean ± sem for control.

Fig. 1. Fetal GSIS. Fetal plasma glucose (A) and insulin (B) concentrations determined for the in vivo GSIS study are presented as the mean ± sem for control.
Figure 1 Body weight of control and BPA-treated mothers after delivery

Figure 1 Body weight of control and BPA-treated mothers after delivery
Fig. 1 Top, Locomotor activity in male bGH transgenic mice (n = 10) and nontransgenic control mice (n = 25) at their first encounter with the locomotor.

Fig. 1 Top, Locomotor activity in male bGH transgenic mice (n = 10) and nontransgenic control mice (n = 25) at their first encounter with the locomotor.
Figure 1. Melatonin levels in CSF of control subjects (n = 82) and AD patients (n = 85). *, P< 0.0001. Decreased Melatonin Levels in Postmortem Cerebrospinal.

Figure 1. Melatonin levels in CSF of control subjects (n = 82) and AD patients (n = 85). *, P< Decreased Melatonin Levels in Postmortem Cerebrospinal.
Figure 1 Lack of endogenous estrogens increases BW and VF in mice fed normal chow or HFD. A, OVX mice (open squares) gain more weight than ovarian-intact.

Figure 1 Lack of endogenous estrogens increases BW and VF in mice fed normal chow or HFD. A, OVX mice (open squares) gain more weight than ovarian-intact.
Figure 4. Inhibition of LPS-induced IL-1β and TNFα, but not IL-6, after exercise. Depicted are LPS-induced IL-1β (upper panel), IL-6 (middle panel), and.

Figure 4. Inhibition of LPS-induced IL-1β and TNFα, but not IL-6, after exercise. Depicted are LPS-induced IL-1β (upper panel), IL-6 (middle panel), and.
From: Nerve Injury-related Autoimmunity Activation Leads to Chronic Inflammation and Chronic Neuropathic Pain Anesthes. 2013;118(2):416-429. doi:10.1097/ALN.0b013e31827d4b82.

From: Nerve Injury-related Autoimmunity Activation Leads to Chronic Inflammation and Chronic Neuropathic Pain Anesthes. 2013;118(2): doi: /ALN.0b013e31827d4b82.

Similar presentations

Ads by Google